Influenza: quantifying morbidity and mortality
- PMID: 3591814
- DOI: 10.1016/0002-9343(87)90556-0
Influenza: quantifying morbidity and mortality
Abstract
Because of their dramatic impact, morbidity and mortality associated with influenza have been recognized since at least the time of Elizabeth I of England. Excess mortality has been documented since 1889, and the infamous 1918 outbreak confirmed that influenza was truly one of the last major plagues. Despite the clear recognition of large clusters of influenza activity, it is still difficult to quantify precisely the total impact of influenza morbidity and mortality, since laboratory confirmation is required for exact diagnosis. Many methods have been developed to provide estimates of the mortality associated with influenza. These methods are usually predicated on establishing expected baseline rates of mortality. Deaths in excess of these rates are then calculated--and attributed to the circulating influenza virus. In this way, groups at high risk of mortality have been defined as the elderly and those with chronic conditions. Special-risk groups, such as those in institutions, have also been identified. The quantification of morbidity has required different approaches, and here community and family studies have made major contributions. In contrast to mortality, morbidity is most pronounced in children and young adults, and the diseases, although self-limited, are often quite severe. Although the size of the outbreaks varies, influenza infection can be documented annually. Thus, each year must be considered an influenza year.
Similar articles
-
Observations on mortality during the 1918 influenza pandemic.Clin Infect Dis. 2001 Oct 15;33(8):1375-8. doi: 10.1086/322662. Epub 2001 Sep 17. Clin Infect Dis. 2001. PMID: 11565078
-
Geography may explain adult mortality from the 1918-20 influenza pandemic.Epidemics. 2011 Mar;3(1):46-60. doi: 10.1016/j.epidem.2011.02.001. Epub 2011 Feb 21. Epidemics. 2011. PMID: 21420659
-
Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004.Epidemiol Infect. 2010 Nov;138(11):1559-68. doi: 10.1017/S0950268810000671. Epub 2010 Mar 25. Epidemiol Infect. 2010. PMID: 20334732
-
The virulence of pandemic influenza A (H1N1) 2009: an epidemiological perspective on the case-fatality ratio.Expert Rev Respir Med. 2010 Jun;4(3):329-38. doi: 10.1586/ers.10.24. Expert Rev Respir Med. 2010. PMID: 20524916 Review.
-
Epidemiology of influenza.Vaccine. 2008 Sep 12;26 Suppl 4:D45-8. doi: 10.1016/j.vaccine.2008.07.066. Vaccine. 2008. PMID: 19230159 Review.
Cited by
-
Influenza surveillance.Bull World Health Organ. 1991;69(5):509-15. Bull World Health Organ. 1991. PMID: 1720356 Free PMC article.
-
Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing.Ther Adv Vaccines Immunother. 2020 Feb 22;8:2515135520908121. doi: 10.1177/2515135520908121. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32128506 Free PMC article. Review.
-
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.J Nat Prod. 2021 Jan 22;84(1):161-182. doi: 10.1021/acs.jnatprod.0c00968. Epub 2020 Dec 22. J Nat Prod. 2021. PMID: 33352046 Free PMC article. Review.
-
Individual and community impact of influenza.Pharmacoeconomics. 1999;16 Suppl 1:1-6. doi: 10.2165/00019053-199916001-00001. Pharmacoeconomics. 1999. PMID: 10623371 Review.
-
[Influenza and cardiorespiratory events: a clinical-epidemiological review with a multidisciplinary point of view].Rev Esp Quimioter. 2021 Dec;34(6):556-568. doi: 10.37201/req/065.2021. Epub 2021 Jul 14. Rev Esp Quimioter. 2021. PMID: 34256558 Free PMC article. Review. Spanish.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical